Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 12, 2011, Pages 2799-2805

  McGrath, Martina M ^a   Isakova, Tamara ^b   Rennke, Helmut G ^a   Mottola, Ann M ^c   Laliberte, Karen A ^c   Niles, John L ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COCAINE; LEVAMISOLE; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE 3 ANTIBODY; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; ANCA ASSOCIATED VASCULITIS; ARTHRALGIA; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; FEMALE; FEVER; HUMAN; LUNG HEMORRHAGE; MALAISE; MALE; MEDICAL RECORD REVIEW; NIGHT SWEAT; REVIEW; SKIN DEFECT; SYSTEMIC DISEASE; WEIGHT REDUCTION;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; COCAINE-RELATED DISORDERS; CREATININE; DRUG CONTAMINATION; FEMALE; HUMANS; LEVAMISOLE; MALE; MIDDLE AGED; MYELOBLASTIN; PEROXIDASE;

EID: 83155182258     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03440411     Document Type: Review

References (47)

1. Substance Abuse and Mental Health Services Administration: Results from the 2008 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-36, HHS Publication No SMA 09-4434, 2009
2. United Nations Office on Drugs and Crime: World drug report, New York, United Nations, 2010
3. Casale JF, Corbel EM, Hays PA: Identification of levamisole impurities found in illicit cocaine exhibits. Microgram Journal 6: 134-137, 2008
4. Agranulocytosis associated with cocaine use-four states, March 2008-November 2009. MMWR Morb Mortal Wkly Rep 58: 1381-1385, 2009
5. Levamisole in rheumatoid arthritis. Final report on a randomised double-blind study comparing a single weekly dose of levamisole with placebo. Multicentre Study Group. Ann Rheum Dis 41: 159-163, 1982
6. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352-358, 1990
7. Menni S, Pistritto G, Gianotti R, Ghio L, Edefonti A: Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 14: 477-479, 1997
8. Laux-End R, Inaebnit D, Gerber HA, Bianchetti MG: Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child 75: 355-356, 1996
9. Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, Edefonti A, Gambini C, Rizzoni G, Rebora A: Purpura of the ears: A distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 140: 948-951, 1999
10. Thompson JS, Herbick JM, Klassen LW, Severson CD, Overlin VL, Blaschke JW, Silverman MA, Vogel CL: Studies on levamisole-induced agranulocytosis. Blood 56: 388-396, 1980
11. Czuchlewski DR, Brackney M, Ewers C, Manna J, Fekrazad MH, Martinez A, Nolte KB, Hjelle B, Rabinowitz I, Curtis BR, McFarland JG, Baumbach J, Foucar K: Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 133: 466-472, 2010
12. Buchanan JA, Vogel JA, Eberhardt AM: Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol 7: 83-84, 2011
13. Gao Y, Zhao MH: Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 14: 33-41, 2009
14. Choi HK, Merkel PA, Walker AM, Niles JL: Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43: 405-413, 2000
15. Wiik A: Drug-induced vasculitis. Curr Opin Rheumatol 20: 35-39, 2008
16. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M: Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: Comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 7: R1072-1081, 2005
17. Akhtari M, Curtis B, Waller EK: Autoimmune neutropenia in adults. Autoimmun Rev 9: 62-66, 2009
18. Bradford M, Rosenberg B, Moreno J, Dumyati G: Bilateral necrosis of earlobes and cheeks: Another complication of cocaine contaminated with levamisole. Ann Intern Med 152: 758-759, 2010
19. Buchanan JA, Oyer RJ, Patel NR, Jacquet GA, Bornikova L, Thienelt C, Shriver DA, Shockley LW, Wilson ML, Hurlbut KM, Lavonas EJ: A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol 6: 160-164, 2010
20. Chang A, Osterloh J, Thomas J: Levamisole: A dangerous new cocaine adulterant. Clin Pharmacol Ther 88: 408-411, 2010
21. Knowles L, Buxton JA, Skuridina N, Achebe I, Legatt D, Fan S, Yan Zhu N, Talbot J: Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct J 6: 30, 2009
22. Wiens MO, Son WK, Ross C, Hayden M, Carleton B: Cases: Cocaine adulterant linked to neutropenia. CMAJ 182: 57-59, 2010
23. Walsh NM, Green PJ, Burlingame RW, Pasternak S, Hanly JG: Cocaine-related retiform purpura: Evidence to incriminate the adulterant, levamisole. J Cutan Pathol 37: 1212-1219, 2010
24. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL: Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126: 866-873, 1997
25. Neynaber S, Mistry-Burchardi N, Rust C, Samtleben W, Burgdorf WH, Seitz MA, Messer G, Wollenberg A: PR3-ANCApositive necrotizing multi-organ vasculitis following cocaine abuse. Acta Derm Venereol 88: 594-596, 2008
26. Tervaert JW, Stegeman CA: A difficult diagnosis. Lancet 364: 1313-1314, 2004
27. Wiesner O, Russell KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, Specks U: Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 50: 2954-2965, 2004
28. Friedman DR, Wolfsthal SD: Cocaine-induced pseudovasculitis. Mayo Clin Proc 80: 671-673, 2005
29. Bhinder SK, Majithia V: Cocaine use and its rheumatic manifestations: A case report and discussion. Clin Rheumatol 26: 1192-1194, 2007
30. Kaye BR, Fainstat M: Cerebral vasculitis associated with cocaine abuse. JAMA 258: 2104-2106, 1987
31. Merkel PA, Koroshetz WJ, Irizarry MC, Cudkowicz ME: Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 25: 172-183, 1995
32. Fredericks RK, Lefkowitz DS, Challa VR, Troost BT: Cerebral vasculitis associated with cocaine abuse. Stroke 22: 1437-1439, 1991
33. Trimarchi M, Gregorini G, Facchetti F, Morassi ML, Manfredini C, Maroldi R, Nicolai P, Russell KA, McDonald TJ, Specks U: Cocaine-induced midline destructive lesions: Clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis. Medicine (Baltimore) 80: 391-404, 2001
34. Plaza G, Espinosa A, Ferrando J, Pinedo F: [Wegener granulomatosis and cocaine-induced midline destructive lesion: differential diagnosis.]. Med Clin (Barc) 133: 237-238, 2009
35. Angit C, Dabrowski MT, Owen CM: Cocaine-induced midline destructive lesion. Clin Exp Dermatol 34: e469-470, 2009
36. Scheenstra RJ, van Buren M, Koopman JP: [A patient with both cocaine-induced nasal septum destruction and antibodies against anti-neutrophil cytoplasmic antibodies (ANCA); potential confusion with Wegener's disease]. Ned Tijdschr Geneeskd 151: 2395-2399, 2007
37. Chen LY, Lin YL, Chiang BL: Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells. Clin Exp Immunol 151: 174-181, 2008
38. Levamisole. Physician's Desk Reference Generics. Montvale, NJ: Medical Economics 1670-1672, 1995
39. Szeto C, Gillespie KM, Mathieson PW: Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance. Immunology 100: 217-224, 2000
40. National Drug Intelligence Centre UDoJ: National Drug Threat Assessment 2010. http://www.justice.gov/ndic/pubs38/ 38661/index.htm
41. Raymon LP, Isenschmid DS: Letter to the editor: The possible role of levamisole in illicit cocaine preparations. J Anal Toxicol 33: 620-622, 2009
42. Spector S, Munjal I, Schmidt DE: Effects of the immunostimulant, levamisole, on opiate withdrawal and levels of endogenous opiate alkaloids and monoamine neurotransmitters in rat brain. Neuropsychopharmacology 19: 417-427, 1998
43. Kouassi E, Caille G, Lery L, Lariviere L, Vezina M: Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 7: 71-89, 1986
44. Reid JM, Kovach JS, O'Connell MJ, Bagniewski PG, Moertel CG: Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer. Cancer Chemother Pharmacol 41: 477-484, 1998
45. Buchanan JA, Heard K, Burbach C, Wilson ML, Dart R: Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA 305: 1657-1658, 2011
46. Barbano G, Ginevri F, Ghiggeri GM, Gusmano R: Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 13: 602-603, 1999
47. Rachapalli SM, Kiely PD: Cocaine-induced midline destructive lesions mimicking ENT-limited Wegener's granulomatosis. Scand J Rheumatol 37: 477-480, 2008